Lymphocytic gastritis accounts for 5% of cases of chronic gastritis. 1 Symptoms are often nonspecific and include abdominal pain, nausea and vomiting, or weight loss. Endoscopic appearance of the mucosa is varied and unreliable as it can appear as nodules, erosions, enlarged and prominent rugae, or normal. Lymphocytic gastritis is characterized by dense and diffuse T-cell lymphocytic infiltration of the gastric epithelium, and it is defined histologically as >25 lymphocytes per 100 epithelial cells, with an average of 50 lymphocytes per 100 epithelial cells. 2 While the etiology of lymphocytic gastritis is unknown, it has important clinical associations with celiac disease and H. pylori infection. 3, 4 In these patients, H. pylori histology may have a reduced sensitivity, and it is recommended patients with lymphocytic gastritis and negative biopsies should undergo serologic testing. 4, 5 Eradication of H. pylori has been shown to be an effective treatment; in one randomized trial, 83% of patients achieved resolution at 3 months and 95.8% at 12 months compared to 53.8% with PPI alone. 4 There is currently no evidence that lymphocytic gastritis is associated with an increased risk of lymphoma or malignancy of the gastrointestinal tract.
To our knowledge, this is the first reported case of lymphocytic gastritis presenting as an abnormal PET finding. We speculate that the increase in intraepithelial lymphocytes and associated inflammation is the etiology of hypermetabolic activity on the PET scan, which would fit with previous reports showing resolution of intraepithelial lymphocytes with PPI therapy. This case highlights that lymphocytic gastritis should be considered as a potential cause of abnormal gastric imaging. 
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